Literature DB >> 14601650

Identification of an HLA-A0201-restricted CTL epitope generated by a tumor-specific frameshift mutation in a coding microsatellite of the OGT gene.

Eva Ripberger1, Michael Linnebacher, Yvette Schwitalle, Johannes Gebert, Magnus von Knebel Doeberitz.   

Abstract

Deficient DNA mismatch repair results in microsatellite instability and might induce shifts of translational reading frames of genes encompassing coding microsatellites. These may be translated in truncated proteins, including neo-peptide tails functioning as tumor rejection antigens, when presented in the context of MHC class I. Recently, others and we identified a frameshift mutation in the coding T(10) microsatellite of the O-linked N-acetylglucosamine transferase gene (OGT) occuring in up to 41% of microsatellite unstable colorectal cancers. Here we describe a novel HLA-A0201-restricted cytotoxic T lymphocyte (CTL)-epitope (28-SLYKFSPFPL; FSP06) derived from this mutant OGT-protein. FSP06-specific CTL-clones killed peptide-sensitized target cells and tumor cell lines expressing both HLA-A0201 and mutant OGT proteins. This demonstrates that FSP06 is endogenously expressed and represents a CD8(+)-T cell epitope. Our data corroborate the concept of frameshift peptides constituting a novel subset of tumor-associated antigens specifically encountered in cancer cells with deficient mismatch repair.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14601650     DOI: 10.1023/a:1025329819121

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  28 in total

1.  Regulated expression of foreign genes in mammalian cells under the control of coliphage T3 RNA polymerase and lac repressor.

Authors:  U Deuschle; R Pepperkok; F B Wang; T J Giordano; W T McAllister; W Ansorge; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

2.  Target gene mutation profile differs between gastrointestinal and endometrial tumors with mismatch repair deficiency.

Authors:  Alex Duval; Maryline Reperant; Aurore Compoint; Raquel Seruca; Guglielmina N Ranzani; Barry Iacopetta; Richard Hamelin
Journal:  Cancer Res       Date:  2002-03-15       Impact factor: 12.701

3.  Expression of HLA class II in colorectal cancer: evidence for enhanced immunogenicity of microsatellite-instability-positive tumours.

Authors:  S A Bustin; S R Li; S Phillips; S Dorudi
Journal:  Tumour Biol       Date:  2001 Sep-Oct

4.  Frequent alterations in the Wnt signaling pathway in colorectal cancer with microsatellite instability.

Authors:  Yosuke Shimizu; Satoshi Ikeda; Masahiko Fujimori; Shinya Kodama; Masahiro Nakahara; Masazumi Okajima; Toshimasa Asahara
Journal:  Genes Chromosomes Cancer       Date:  2002-01       Impact factor: 5.006

5.  Source of unique tumour antigens.

Authors:  A Townsend; C Ohlén; M Rogers; J Edwards; S Mukherjee; J Bastin
Journal:  Nature       Date:  1994-10-20       Impact factor: 49.962

6.  High prevalence of activated intraepithelial cytotoxic T lymphocytes and increased neoplastic cell apoptosis in colorectal carcinomas with microsatellite instability.

Authors:  R Dolcetti; A Viel; C Doglioni; A Russo; M Guidoboni; E Capozzi; N Vecchiato; E Macrì; M Fornasarig; M Boiocchi
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

7.  Frequent somatic mutations of hMSH3 with reference to microsatellite instability in hereditary nonpolyposis colorectal cancers.

Authors:  Y Akiyama; N Tsubouchi; Y Yuasa
Journal:  Biochem Biophys Res Commun       Date:  1997-07-18       Impact factor: 3.575

8.  Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype.

Authors:  N Rampino; H Yamamoto; Y Ionov; Y Li; H Sawai; J C Reed; M Perucho
Journal:  Science       Date:  1997-02-14       Impact factor: 47.728

Review 9.  An update on Lynch syndrome.

Authors:  H T Lynch; T Smyrk
Journal:  Curr Opin Oncol       Date:  1998-07       Impact factor: 3.645

10.  Identification of MARCKS, FLJ11383 and TAF1B as putative novel target genes in colorectal carcinomas with microsatellite instability.

Authors:  Nam-Gyun Kim; Hwanseok Rhee; Long Shan Li; Hyunki Kim; Jin-Sung Lee; Joo-Hang Kim; Nam Kyu Kim; Hoguen Kim
Journal:  Oncogene       Date:  2002-08-01       Impact factor: 9.867

View more
  21 in total

1.  Somatic mutations of the coding microsatellites within the beta-2-microglobulin gene in mismatch repair-deficient colorectal cancers and adenomas.

Authors:  Mark Clendenning; Alvin Huang; Harindra Jayasekara; Marie Lorans; Susan Preston; Neil O'Callaghan; Bernard J Pope; Finlay A Macrae; Ingrid M Winship; Roger L Milne; Graham G Giles; Dallas R English; John L Hopper; Aung K Win; Mark A Jenkins; Melissa C Southey; Christophe Rosty; Daniel D Buchanan
Journal:  Fam Cancer       Date:  2018-01       Impact factor: 2.375

2.  Reactivity against microsatellite instability-induced frameshift mutations in patients with inflammatory bowel disease.

Authors:  Florian Kuehn; Ernst Klar; Anja Bliemeister; Michael Linnebacher
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

Review 3.  HLA antigen and NK cell activating ligand expression in malignant cells: a story of loss or acquisition.

Authors:  Michael Campoli; Soldano Ferrone
Journal:  Semin Immunopathol       Date:  2011-04-28       Impact factor: 9.623

Review 4.  [Molecular pathogenesis. Its importance in targeted therapy in colorectal cancer].

Authors:  M Kloor; S Michel; M von Knebel Doeberitz
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

5.  Identification of an MSI-H tumor-specific cytotoxic T cell epitope generated by the (-1) frame of U79260(FTO).

Authors:  Michael Linnebacher; Anne Wienck; Inga Boeck; Ernst Klar
Journal:  J Biomed Biotechnol       Date:  2010-03-18

Review 6.  Human endogenous retroviruses and cancer: causality and therapeutic possibilities.

Authors:  Christina S Mullins; Michael Linnebacher
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

Review 7.  Towards a vaccine to prevent cancer in Lynch syndrome patients.

Authors:  Magnus von Knebel Doeberitz; Matthias Kloor
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

8.  Both treated and untreated tumors are eliminated by short hairpin RNA-based induction of target-specific immune responses.

Authors:  Wenyi Gu; Melanie Cochrane; Graham R Leggatt; Elizabeth Payne; Allison Choyce; Fang Zhou; Robert Tindle; Nigel A J McMillan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-04       Impact factor: 11.205

Review 9.  Colorectal cancer and immunity: what we know and perspectives.

Authors:  Simon Pernot; Magali Terme; Thibault Voron; Orianne Colussi; Elie Marcheteau; Eric Tartour; Julien Taieb
Journal:  World J Gastroenterol       Date:  2014-04-14       Impact factor: 5.742

Review 10.  Immunology of Lynch Syndrome.

Authors:  Danielle M Pastor; Jeffrey Schlom
Journal:  Curr Oncol Rep       Date:  2021-06-14       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.